Clinic
White County Medical Center
White County Medical Center was paid $10.21M by Medicaid between Jan 2018 and Dec 2024, across 163 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.
33Billing provider infoWHITE COUNTY MEDICAL CENTER
SEARCY, AR 72143
SEARCY, AR 72143
33aNPI1962784835assigned 09/15/2011
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$10.21M
24GClaims392,477
24DCodes billed163
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Arkansas
Rank by total paid#4 of 24
Median peer was paid$566K
This provider vs. median18×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 51,676 | $1.42M | |
| 2019 | 60,743 | $1.59M | |
| 2020 | 58,932 | $1.52M | |
| 2021 | 65,331 | $1.77M | |
| 2022 | 62,786 | $1.72M | |
| 2023 | 59,298 | $1.25M | |
| 2024incomplete | 33,711 | $941K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 130,358 | 107,437 | $3.81M |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 7.5% | 10,213 | 8,780 | $762K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.9% | 14,599 | 12,276 | $701K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.5% | 11,914 | 10,130 | $562K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.4% | 19,245 | 16,064 | $447K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 4.1% | 29,600 | 23,386 | $422K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 4.0% | 3,893 | 3,551 | $413K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.4% | 7,172 | 6,454 | $348K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.8% | 7,738 | 5,821 | $285K |
| 99222 | Initial hospital care, per day, moderate complexity | 2.7% | 5,477 | 3,703 | $277K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.8% | 3,871 | 3,315 | $183K |
| 99460 | 1.3% | 1,577 | 1,349 | $136K |
151 more codes
| 99308 | Subsequent nursing facility care, per day, straightforward | 1.0% | 12,757 | $105K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.0% | 822 | $104K |
| 20610 | <1% | 2,817 | $95K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,829 | $90K |
| 90670 | <1% | 7,831 | $82K | |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 143 | $80K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 14,042 | $79K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,057 | $77K |
| 99223 | Prolong inpt eval add15 m | <1% | 801 | $73K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,929 | $72K |
| 90698 | <1% | 6,155 | $71K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,706 | $69K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 7,170 | $63K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,516 | $57K |
| 90680 | <1% | 5,423 | $57K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,154 | $56K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 4,669 | $49K |
| 90633 | <1% | 3,107 | $32K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,335 | $31K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 835 | $30K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 833 | $30K |
| 90744 | <1% | 2,802 | $29K | |
| 90688 | <1% | 2,630 | $29K | |
| 90710 | <1% | 2,054 | $23K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 1,131 | $21K |
| 99402 | <1% | 405 | $21K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 1,180 | $20K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,197 | $20K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 556 | $20K |
| 80053 | Comprehensive metabolic panel | <1% | 2,290 | $17K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 335 | $14K |
| 95115 | <1% | 1,391 | $13K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 465 | $13K |
| 87276 | <1% | 1,061 | $13K | |
| 90697 | <1% | 864 | $12K | |
| 90671 | <1% | 891 | $10K | |
| 99205 | Prolong outpt/office vis | <1% | 131 | $10K |
| 90734 | <1% | 871 | $10K | |
| 81001 | <1% | 2,919 | $9K | |
| 92567 | <1% | 911 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,796 | $7K |
| 86403 | <1% | 496 | $6K | |
| 87275 | <1% | 534 | $6K | |
| 0001A | <1% | 216 | $6K | |
| 0002A | <1% | 198 | $6K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 426 | $6K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 24 | $6K |
| 90723 | <1% | 449 | $5K | |
| 73110 | <1% | 467 | $5K | |
| 54150 | <1% | 28 | $5K | |
| 90715 | <1% | 457 | $5K | |
| 86703 | <1% | 331 | $5K | |
| 90696 | <1% | 390 | $4K | |
| 87400 | <1% | 799 | $3K | |
| 73630 | <1% | 213 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,498 | $3K |
| 87280 | <1% | 286 | $3K | |
| 93971 | <1% | 203 | $3K | |
| 92557 | <1% | 221 | $3K | |
| 87420 | <1% | 251 | $3K | |
| 73562 | <1% | 237 | $3K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 17 | $3K |
| 90619 | <1% | 155 | $3K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 379 | $2K |
| 73030 | <1% | 150 | $2K | |
| 86140 | <1% | 605 | $2K | |
| 80061 | Lipid panel | <1% | 926 | $2K |
| 99221 | <1% | 83 | $2K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 50 | $2K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 888 | $2K |
| 85651 | <1% | 727 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 115 | $2K |
| 52332 | <1% | 16 | $2K | |
| 95886 | <1% | 29 | $1K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 373 | $1K |
| 90649 | <1% | 141 | $1K | |
| 73564 | <1% | 90 | $1K | |
| 82948 | <1% | 316 | $1K | |
| 90651 | <1% | 91 | $1K | |
| 73502 | <1% | 98 | $1K | |
| 90685 | <1% | 106 | $1K | |
| 86701 | <1% | 97 | $1K | |
| 99318 | <1% | 76 | $999.36 | |
| 95909 | <1% | 23 | $993.59 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 77 | $974.43 |
| 73610 | <1% | 92 | $883.70 | |
| 92555 | <1% | 106 | $870.58 | |
| 99219 | <1% | 14 | $761.31 | |
| 93880 | <1% | 43 | $739.99 | |
| 99381 | <1% | 12 | $732.12 | |
| 90648 | <1% | 78 | $726.56 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 159 | $726.42 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 527 | $702.38 |
| 90681 | <1% | 52 | $630.72 | |
| 72110 | <1% | 19 | $591.37 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 15 | $571.65 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 496 | $529.87 |
| 73130 | <1% | 34 | $500.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 55 | $417.05 |
| 99217 | <1% | 17 | $371.27 | |
| 80055 | <1% | 12 | $365.20 | |
| 90707 | <1% | 28 | $341.64 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 163 | $333.28 |
| 90714 | <1% | 27 | $315.36 | |
| 90658 | <1% | 23 | $298.83 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 421 | $251.91 |
| 99401 | <1% | 15 | $247.50 | |
| 84439 | <1% | 108 | $239.55 | |
| 74420 | <1% | 20 | $208.90 | |
| 83655 | <1% | 14 | $204.64 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 448 | $192.36 |
| 99442 | <1% | 37 | $190.00 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,451 | $151.38 |
| 85018 | <1% | 70 | $141.96 | |
| 85014 | <1% | 70 | $141.96 | |
| 81003 | <1% | 70 | $128.32 | |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 36 | $124.44 |
| G0008 | Administration of influenza virus vaccine | <1% | 430 | $116.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14 | $115.30 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 15 | $104.16 |
| 87081 | <1% | 13 | $75.76 | |
| 81025 | <1% | 113 | $67.53 | |
| 82465 | <1% | 18 | $56.48 | |
| 0003A | <1% | 63 | $38.47 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 40 | $27.63 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 105 | $14.19 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 58 | $13.33 |
| 99441 | <1% | 59 | $5.75 | |
| 90662 | <1% | 208 | $2.34 | |
| 91300 | <1% | 16 | $0.02 | |
| 1036F | 0% | 1,751 | $0.00 | |
| 1101F | 0% | 280 | $0.00 | |
| 1000F | 0% | 2,485 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 882 | $0.00 |
| 3074F | 0% | 655 | $0.00 | |
| 1125F | 0% | 79 | $0.00 | |
| 1220F | 0% | 72 | $0.00 | |
| 3008F | 0% | 166 | $0.00 | |
| 3079F | 0% | 14 | $0.00 | |
| 3075F | 0% | 14 | $0.00 | |
| 1159F | 0% | 2,363 | $0.00 | |
| 1160F | 0% | 2,682 | $0.00 | |
| 3288F | 0% | 2,227 | $0.00 | |
| 3078F | 0% | 735 | $0.00 | |
| 85007 | 0% | 51 | $0.00 | |
| 99001 | 0% | 99 | $0.00 | |
| 3725F | 0% | 41 | $0.00 | |
| 0518F | 0% | 14 | $0.00 | |
| 3077F | 0% | 15 | $0.00 | |
| 3015F | 0% | 56 | $0.00 | |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 0% | 92 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPOOL, CASSIE (CREDENTIALING SPECIALIST)
| Provider | Location | Paid |
|---|---|---|
| Unity Health - Newport | Newport, AR | $112K |
| Unity Health - Newport | Newport, AR | $50K |
| Unity Health - Newport | Newport, AR | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.